S. Califice

Dual activities of galectin-3 in human prostate cancer: tumor suppression of nuclear galectin-3 vs tumor promotion of cytoplasmic galectin-3

V. Castronovo, M. Bracke, S. Califice, 2004, Oncogene.

MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma.

J. Menten, R. Sciot, B. Neyns, 2009, European journal of cancer.

Validation of real-time methylation-specific PCR to determine O6-methylguanine-DNA methyltransferase gene promoter methylation in glioma.

M. Delorenzi, M. Hegi, M. Hamou, 2008, The Journal of molecular diagnostics : JMD.

Expression of galectins in cancer: A critical review

V. Castronovo, Vincent Castronovo, Frédéric van den Brûle, 2004, Glycoconjugate Journal.

Galectin-1 Accumulation in the Ovary Carcinoma Peritumoral Stroma Is Induced by Ovary Carcinoma Cells and Affects Both Cancer Cell Proliferation and Adhesion to Laminin-1 and Fibronectin

A. Berchuck, V. Castronovo, P. Fernández, 2003, Laboratory Investigation.

Galectin-3 and cancer (Review).

V. Castronovo, F. van den Brûle, S. Califice, 2004, International journal of oncology.

Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of Sulfasalazine for the treatment of progressing malignant gliomas in adults

M. Bredel, V. Bours, Didier Martin, 2009, BMC Cancer.